[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various cancers. The company's two clinical programs Amezalpat formerly PST-1120, an oral, small molecule, selective antagonist of peroxisome proliferator-activated receptor alpha, which is in Phase III; and TPST-1495, a novel, small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, which is in Phase II. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 923235, "exercisedValue": 0, "unexercisedValue": 262204}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 43, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 465429, "exercisedValue": 0, "unexercisedValue": 67328}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 57, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 667651, "exercisedValue": 0, "unexercisedValue": 93438}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.05, "open": 7.9318, "dayLow": 7.6583, "dayHigh": 7.975, "regularMarketPreviousClose": 8.05, "regularMarketOpen": 7.9318, "regularMarketDayLow": 7.6583, "regularMarketDayHigh": 7.975, "payoutRatio": 0.0, "beta": -2.283, "forwardPE": -5.6231885, "volume": 26185, "regularMarketVolume": 26185, "averageVolume": 61831, "averageVolume10days": 61170, "averageDailyVolume10Day": 61170, "bid": 7.67, "ask": 7.99, "bidSize": 1, "askSize": 1, "marketCap": 28338590, "fiftyTwoWeekLow": 5.356, "fiftyTwoWeekHigh": 49.27, "fiftyDayAverage": 9.65724, "twoHundredDayAverage": 13.945245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12247090, "profitMargins": 0.0, "floatShares": 3222289, "sharesOutstanding": 3520320, "sharesShort": 125691, "sharesShortPriorMonth": 164115, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0359, "heldPercentInsiders": 0.00141, "heldPercentInstitutions": 0.14818, "shortRatio": 3.38, "shortPercentOfFloat": 0.039, "impliedSharesOutstanding": 3651880, "bookValue": 5.655, "priceToBook": 1.372237, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -41843000, "trailingEps": -19.5, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.294, "52WeekChange": -0.82647586, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 7.76, "targetHighPrice": 207.99994, "targetLowPrice": 9.0, "targetMeanPrice": 102.99997, "targetMedianPrice": 97.49997, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 30268000, "totalCashPerShare": 8.651, "ebitda": -41637000, "totalDebt": 15365000, "quickRatio": 2.129, "currentRatio": 2.213, "debtToEquity": 80.336, "returnOnAssets": -0.56431, "returnOnEquity": -1.82346, "freeCashflow": -19081750, "operatingCashflow": -33027000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "marketState": "CLOSED", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1745623823, "regularMarketTime": 1745611202, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.6024837, "regularMarketPrice": 7.76, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": 1.54639, "postMarketPrice": 7.88, "postMarketChange": 0.12, "regularMarketChange": -0.28999996, "regularMarketDayRange": "7.6583 - 7.975", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 61831, "fiftyTwoWeekLowChange": 2.4040003, "fiftyTwoWeekLowChangePercent": 0.44884247, "fiftyTwoWeekRange": "5.356 - 49.27", "fiftyTwoWeekHighChange": -41.510002, "fiftyTwoWeekHighChangePercent": -0.84250057, "fiftyTwoWeekChangePercent": -82.64758, "dividendDate": 1544400000, "earningsTimestamp": 1743106257, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -19.5, "epsForward": -1.38, "epsCurrentYear": -15.2525, "priceEpsCurrentYear": -0.5087691, "fiftyDayAverageChange": -1.8972397, "fiftyDayAverageChangePercent": -0.19645776, "twoHundredDayAverageChange": -6.1852446, "twoHundredDayAverageChangePercent": -0.4435379, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-04-21", "averageAnalystRating": "2.0 - Buy", "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]